FemInnovation Bethany Corbin

The exclusion of women from modern medicine is a complex and pervasive issue that spans centuries of medical practice. Despite advancements in healthcare, women continue to face systemic barriers that hinder their access to accurate diagnosis, appropriate treatment, and equitable care. Historical biases, gender stereotypes, and a lack of representation in medical research have contributed to this exclusion, perpetuating disparities in health outcomes and quality of care. From underrepresentation in clinical trials to the dismissal of women’s symptoms and concerns, the consequences of this exclusion are far-reaching, impacting women’s health across diverse populations. 
In this episode of FemInnovation, host Bethany Corbin talks with Dr. Elizabeth Comen, author of the USA Today bestselling book “All in Her Head”, about the exclusion of women from medicine and how women today can advocate for their health and wellbeing in a world designed for men.  Specifically, Bethany and Dr. Comen dive into the shame and stigma women encounter when trying to discuss their health concerns, the equation of women’s health with reproductive health, how bias in medicine affects both patients and providers, the societal need to control women, whether femtech is the answer to the exclusion of women in medicine, and how to change the ongoing narrative of women’s health. Join us for this enlightening conversation to help shift the future trajectory of women’s health worldwide.
About Dr. Elizabeth Comen:
Elizabeth Comen, MD, has dedicated her medical career to saving the lives of women.  An award-winning, internationally sought-after clinician and physician-scientist, Dr. Comen works as a medical oncologist in New York City and is an assistant professor of medicine at Weill Cornell Medical College. She earned her BA in the history of science from Harvard College and her MD from Harvard Medical School, then completed her residency in Internal Medicine at Mount Sinai Hospital and her fellowship in oncology at Memorial Sloan Kettering Cancer Center. She lives in New York City with her family. 
RELEVANT LINKS: 
Learn more about Dr. Comen at this website. Learn more about Dr. Comen’s USA Today bestselling book “All in Her Head” at this website. Purchase “All in Her Head” at HarperCollins and Amazon.  Connect with Our Guest, Dr. Comen: LINKEDIN | INSTAGRAM
 Follow Our Host, Bethany Corbin: WEBSITE | LINKEDIN | INSTAGRAM | ADDITIONAL LINKS

Commercializing your femtech or healthtech product can be challenging, especially for early-stage founders. Bringing a product to market often involves detailed customer research and product testing, developing impactful launch and communication strategies, removing barriers to consumer adoption, identification of the proper reimbursement pathway, and more. In this episode of the FemInnovation Podcast, host Bethany Corbin sits down with Swathi Rangan and Daniella Kapural from Herspiegel to discuss the secrets for product commercialization success. The trio discusses what product commercialization means, when femtech founders should start thinking about a product commercialization strategy, common product commercialization mistakes, how to identify applicable business models, how to determine product differentiators and develop a value proposition, and much more! Don’t miss this in-depth discussion to enhance your product commercialization strategy and experience. 
 About Swathi Rangan:
As a Principal at Herspiegel, Swathi leverages her passion and expertise within the sciences and strong problem-solving skills to help pharmaceutical clients swiftly address complex business challenges. She excels at developing and leading teams to craft successful commercial solutions, in collaboration with the client.
Throughout her tenure at Herspiegel, Swathi has led projects with a variety of clients, ranging from large to mid-size, and start-ups. She has deep knowledge in a variety of therapeutic areas including women's health, immunology, oncology, cardiometabolic disorders, and rare disease. Her expertise includes leading strategy and implementation across commercial projects with a strong focus on data and insight-driven innovation; projects include patient support and experience design, digital health partnership implementation, and go-to-market strategy development. She also specializes in creating comprehensive market-shaping strategies for complex disease states and has successfully managed numerous product launches.
About Daniella Kapural: 
Daniella began her consulting career at Herspiegel with a fervent commitment to enhancing the patient experience through strategic problem-solving and innovation. During her tenure, she cultivated a passion for advancing women's health, focusing on devising solutions to address the diverse and complex healthcare needs unique to women across the continuum of care.
As a Consultant, she has demonstrated exceptional leadership and support across a diverse array of projects, encompassing product launch, brand planning, go-to-market strategy development, digital health integration, and change management implementation. She serves a broad spectrum of clients, ranging from start-ups to established pharmaceutical giants, lending her expertise across various therapeutic areas such as women's health, oncology, cardiovascular disorders, and neurology. 
RELEVANT LINKS: 
More about Herspiegel at this website. Connect with Swathi Rangan on Linkedin. Connect with Daniella Kapural on LinkedIn. Follow Our Host, Bethany Corbin: WEBSITE | LINKEDIN | INSTAGRAM | ADDITIONAL LINKS

Since the onset of the COVID-19 pandemic, digital health tools have proliferated as a way for consumers to access care virtually and monitor their health conditions at home. State and federal laws have been modified to expand care settings and enhance the accessibility of healthcare services. Digital health solutions, however, are still unavailable to large portions of the population, resulting in inequitable access to care that has, at times, been exacerbated by the digital health revolution. Key barriers to digital health adoption include digital literacy, inconsistent access to broadband and high-speed internet, lack of access to smartphones and cell service, and cultural competency. 

In this episode of FemInnovation, host Bethany Corbin sits down with Priya Bathija, a nationally recognized healthcare leader, attorney, and policy expert, to explore how femtech founders can enhance digital health equity. This episode explores the fundamentals of digital health equity, why digital health equity is essential in today's healthcare landscape, the impact socioeconomic factors have on digital health tools and resources, successful strategies for improving access to digital health services, how founders can design their products with digital health equity in mind, and much more! Don't miss this exciting episode designed to help founders and digital health enthusiasts bridge the digital divide.  

RELEVANT LINKS: 
More about Nyoo Health at this website. Read Priya’s Article in the Journal of Health and Life Sciences Law on “Digital Health Equity: Narrowing the Digital Divide by Ensuring a Fair, Equitable, and Just Opportunity to Access Digital Health” at this website.  Connect with Our Guest, Priya Bathija: LINKEDIN
 Follow Our Host, Bethany Corbin: WEBSITE | LINKEDIN | INSTAGRAM | ADDITIONAL LINKS

On International Women's Day 2024, FemInnovation is dropping a special episode with a special announcement: the launch of the Women's Digital Health Network (WDHN)! The WDHN is committed to driving meaningful and innovative advancement in healthcare through sustained communications and collaborations with federal agencies, Congress, the women's digital health industry, and nonprofits. Learn about why the WDHN was created, its goals and objectives, and how to take part in this brand new initiative! We'll be following up with a regular episode on the WDHN with more information, but we're thrilled to bring you this special announcement today and to keep advancing the momentum in women's health and femtech. 

Join the Women's Digital Health Network @ This Website 
Learn More About WDHN's Founders:
Liz Powell: LinkedIn | G2G Consulting Website Nada Hanafi: LinkedIn | MedTech Color Website Bethany Corbin: LinkedIn | FemInnovation Website 

Determining whether and how to integrate artificial intelligence into your femtech product can feel like a daunting task. In today’s world of AI, big data, and machine learning, it can be tempting to assume that your product needs to incorporate AI to attract investment or secure a competitive advantage. While AI certainly has a place in femtech, its incorporation into your product should be deliberate and meaningful and provide recognizable value to your users. Otherwise, founders risk artificially inflating the price and complexity of their products without providing value to their consumers. 
In this special episode of the FemInnovation Podcast, host Bethany Corbin talks with data and AI expert Gilad Barash about how to determine whether your femtech product needs AI and whether the “sensationalization” of AI is warranted. Gilad is a data and AI strategist and analytics leader who has worked for companies at the cutting edge of data. His 15 years of using data and AI to solve complex business problems has led him to start asking the hard questions about how data affects our everyday lives and how our lives in turn create data. Gilad explores these questions through his internationally recognized podcast “Who’s Your Data?” where he interviews industry thought leaders and discusses how data and AI affect different industries as well as their influence on social change. Don’t miss this exciting episode where Bethany and Gilad dive into the data hierarchy of needs (i.e., how to think about data and AI for your startup), the biases present in AI data sets, the crucial questions that startups need to ask themselves about data and AI, and the fundamentals of generative AI. 
RELEVANT LINKS: 
More about the Who’s Your Data? Podcast at this website.Read Gilad’s Article on The Femtech Frontier: Embracing AI for Women’s Health in 2024 at this website.Sign Up for a Co-Hosted Webinar by Bethany and Gilad on AI Readiness in Femtech: Navigating the Data Hierarchy of Needs (February 21st at 12:00 pm EST). Register at this website.   Connect with Our Guest, Gilad Barash: LINKEDIN
 Follow Our Host, Bethany Corbin: WEBSITE | LINKEDIN | INSTAGRAM | ADDITIONAL LINKS

Navigating the pitfalls and challenges in the femtech industry can be daunting. From raising capital (in an environment where less than 4% of research and development funding goes to women’s health) to ensuring clinical accuracy of femtech products (with studies showing that 85% of femtech apps don’t meet ORCHA’s clinical quality threshold) to negotiating contracts with payers and employers, operating in the femtech industry takes resilience and passion. 
 In this episode of FemInnovation, host Bethany Corbin sits down with Dr. Mitzi Krockover to discuss the evolving landscape of women’s health as it relates to funding, clinical accuracy, and business adoption. Mitzi is a fierce women’s health advocate and the Founding Medical Director of the Iris Cantor-UCLA Women’s Health Center. Mitzi also served as the Vice President of Women’s Health at Humana and is the current Managing Director of the Arizona Chapter of Golden Seeds, an angel investing network. Mitzi is the host of the Beyond the Paper Gown Podcast and serves on Springboard’s Women’s Health Executive Committee. Bethany and Mitzi discuss the barriers to clinical adoption of femtech products, how payers and employers evaluate femtech devices, the importance of advisory boards, the role of angel investors, and much more. You won’t want to miss this conversation by a powerhouse duo in women’s health! 
RELEVANT LINKS: 
More about Beyond the Paper Gown at this website.More about Mitzi Krockover at this website. Follow Beyond the Paper Gown @Instagram. Connect with Our Guest, Dr. Mitzi Krockover: LINKEDIN | INSTAGRAM
Follow Our Host, Bethany Corbin: WEBSITE | LINKEDIN | INSTAGRAM | ADDITIONAL LINKS